Pathways 2 Success
Pathways 2 Success: A Study of School-Based Prevention Programs Supporting Positive Adolescent Development
University of Minnesota
120 participants
Mar 12, 2025
INTERVENTIONAL
Conditions
Summary
This study involves a 3-arm randomized controlled trial designed to investigate the feasibility and acceptability of three preventive interventions designed to reduce risk for escalations in adolescent conduct problems. High school students identified to be at risk for conduct problems will be randomly assigned to one of three intervention options, including a mindfulness-based program, a mindfulness-based program augmented by a new mobile app, and a life skills program. Assessments related to intervention outcomes will be completed by adolescents, parents/guardians, and teachers at baseline, 2 weeks post-intervention, and at a 3-month follow-up.
Eligibility
Inclusion Criteria3
- A 9th or 10th grade student in a partner school district
- Referral due to elevated social/emotional risk indicated on a standardized screening tool or a referral from school support staff due to concerns about school-based conduct problems
- Adolescents and their parents must be fluent in English
Exclusion Criteria2
- Currently receiving special education services (i.e., an IEP) due to a behavioral or emotional disturbance
- Existing diagnoses of autism spectrum disorder, pervasive developmental disorders, developmental/intellectual disability, or serious psychiatric disorders requiring specialized mental health treatment (e.g., psychosis, bipolar, substance use disorder, etc.)
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
a 6-session, group-based intervention that helps youth develop mindfulness skills
the Learning to Breathe plus App condition, the 6-session L2B intervention augmented by a mobile application designed to support the use of mindfulness skills in daily life
a 6-session life skills intervention designed to support decision making and healthy relationships
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06831123